[1]BioorganicandMedicinalChemistry,2012,vol.20,p.69-85
[1]Synlett,2017,vol.28,p.1636-1640
[1]CurrentPatentAssignee:BEIJINGNUOCHENGJIANHUAMEDICINETECH;BEIJINGINNOCAREPHARMATECH-CN113135910,2021,ALocationinpatent:Paragraph0183-0185;0191-0194
16205-44-0
1062368-70-0
1356144-48-3
1062368-71-1
1211596-19-8
55899-30-4
513246-99-6 | 4-(Piperazin-1-yl)phenylboronic acid | AA00DKDB | MFCD09608131
497159-91-8 | 2-(N,N-BisBOC-amino)-5-bromo-3-methylpyridine | AA00DKIC | MFCD11111840
4349-08-0 | 5-Chloropyrimidin-4-ol | AA00DKPM | MFCD09750156
486422-70-2 | 4-(4-Ethylpiperazin-1-ylsulfonyl)phenylboronic acid | AA00DL3H | MFCD26397905
4742-01-2 | N1-Phenylpropane-1,3-diamine | AA00DLBV | MFCD00047968
445302-27-2 | 1-(4-Bromophenyl)-1H-imidazole-4-carboxylic acid | AA00DLQO | MFCD16666931
478968-48-8 | Ethyl 3-methoxy-1h-pyrazole-4-carboxylate | AA00DM08 | MFCD13689107
474397-16-5 | 4-(4-Methylpyrimidin-2-yl)aniline | AA00DNKH | MFCD18330648
442150-49-4 | 6-Bromo-1-fluoronaphthalen-2-ol | AA00DPZ0 | MFCD22570575
5286-10-2 | Lythrine | AA00DRBA